Introduction After the WHO prequalified the first vaccine against mpox, we aimed to identify the influence of vaccine ...
Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results